Doctor's Notes

Rubber Allergy in Sports: A 43-Student Patch-Test Study

Premium Life in Motion editorial illustration for Rubber Allergy in Sports: A 43-Student Patch-Test Study; fictional scene using the actual Dr. Arsy #003 4 oz jar

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work or activity settings. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

The practical question

This study concerns symptomatic referred students; it does not show that one quarter of all athletes have rubber allergy.

This research becomes useful only when its population, denominator, design and timepoint remain attached. A percentage from a referral clinic, workforce survey or prevention program is not an individual prediction and cannot diagnose why one person’s skin changed.

Study snapshot

Study element Reported detail
Population 43 students aged 13–28 with eczematous lesions referred by sports institutions
Design Selected case series with patch testing and latex-specific IgE testing
Timepoint Single diagnostic assessment after at least three years of sports participation
Key result 10 of 43 reacted to thiurams (23.3%), 9 to mercaptobenzothiazole (20.9%), and 2 had positive latex-specific IgE tests

What the numbers can—and cannot—say

10 of 43 reacted to thiurams (23.3%), 9 to mercaptobenzothiazole (20.9%), and 2 had positive latex-specific IgE tests.

There was no population-based control group, the sample was small and preselected, and sensitization needs clinical relevance to explain dermatitis.

That boundary matters. Cross-sectional associations cannot show which came first. Patch-test positivity requires clinical relevance. A workplace program may combine substitution, training, gloves, washing and clinical care, so improvement cannot automatically be assigned to one component.

Turn the study into a better exposure history

Record the exact task, material or equipment, contact site, frequency, wet-work duration, glove type, cleanser, symptom timing, days away from exposure and functional effect. Compare workdays with days off without deliberately re-exposing skin. Photographs and a product or safety-data list can help a clinician or occupational-health team reconstruct the sequence.

Prevention follows a hierarchy: eliminate or substitute hazards where feasible, control splashes or aerosols, improve workflow and training, then use correctly selected protective equipment. A moisturizer can support dry-skin comfort; it cannot neutralize an allergen, corrosive chemical, contaminated water or friction hazard.

Practical questions for work, sport or school

  • Was the study population similar to this person, or already selected because symptoms were present?
  • Does the distribution match the suspected equipment, material, uniform or task?
  • Would clinician-directed patch testing or occupational review change the plan?
  • What outcome will be tracked: severity, sleep, function, absence, productivity or safe participation?
  • What would trigger urgent evaluation, such as rapidly spreading redness, drainage, fever, severe pain or major functional loss?

Primary and authoritative sources

PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.

Where a cosmetic moisturizer fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.

Bottom line

The responsible conclusion is the narrow one: preserve the denominator, comparator, timepoint and limitations, then use the study to ask better clinical and exposure-control questions rather than to promise a universal result.

Educational content only. Researchers and cited organizations do not endorse Dr. Arsy.

← Back to Doctor's Notes